← All companies

RVRC

Revium Rx.

RVRC OTC Pharmaceutical Preparations EDGAR ↗

$1.67

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$101M

Revenue (TTM)

—

Net income (TTM)

-$13.4M

EPS (TTM)

$-0.22

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$920K

Total assets

$7.75M

Gross margin

—

52-week range

$0.52 – $1.67

Recent SEC filings

12 most recent

Annual, quarterly & current reports

8-K Director or officer change Jun 22, 2026 8-K Director or officer change Jun 1, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026

Other filings

EFFECT Jan 30, 2026 S-1/A AMENDMENT NO. 5 TO FORM S-1 Jan 28, 2026 S-1/A AMENDMENT NO. 4 TO FORM S-1 Jan 16, 2026 S-1/A AMENDMENT NO. 3 TO FORM S-1 Dec 12, 2025 S-1/A AMENDMENT NO. 2 TO FORM S-1 Oct 3, 2025 S-1/A AMENDMENT NO. 1 TO FORM S-1 Aug 13, 2025 S-1 REGISTRATION STATEMENT Feb 14, 2025